Open Demat Account
Become a
New
Partner
Financial
Services
Financial
Planning
Analyse
Portfolio
Investment
Platforms
Login
Flip
FundsGenie
Smartfolios
PMS
MyGeojit
Open Demat Account
Support
Equity
Mutual Funds
Portfolio Management
Currency Futures
IPO
Smartfolios
NEW
Sovereign Gold Bond
Commodity
Insurance
Depository Services
Global Investments
NEW
Margin Trading Funding
Private Wealth
NRI Services
Alternative Investment Funds
FundsGenie for Mutual Funds
Mutual Funds Sahi Hai!
Login to FundsGenie
Or Download the Mobile App
Equity
Margin Trading Funding
Smartfolios
NEW
Currency Futures
Depository Services
Commodity
IPO
Sovereign Gold Bond
To avail the service, you will be redirected to loans.geojitcredits.com
Continue
Close
Search
ALL
Company
News
NAV
Site Search
Please wait ...
Home
Equity
Index Details -Pharmaceuticals - Indian - Formulations
Share
Kilitch Drugs (India) Ltd Share Price
Pharmaceuticals - Indian - Formulations
Buy
Ask Expert
Background
Balance sheet
Profit & Loss
Quarterly Results
Share Prices
Bonus History
Capital History
Key Financial Ratios
Director's Report
Score Board
Peer Comparison
Deliverable Volumes
NSE
BSE
154.02
153.30
Date :
Apr 30,2026 EOD
-0.09
(-0.06)
+0.36
(0.55 )
1D
1W
1M
3M
1Y
Stock Price Details
Open Price
(₹)
153.60
Buy (size)
0.00(x0)
Sell (size)
0.00(×0)
Buy Qty
0
Sell Qty
0
Today's High
(₹)
155.70
Today's Low
(₹)
149.00
52 Week High
(₹)
250.00
52 Week Low
(₹)
117.25
Market Statistics
Div Yield (%)
0
EPS
8.52
Book Value
75.99
Market Cap
535.96
Face Value
10
Market Lot
1
AGM Date
Sep
Closure Date
Sep
ISIN No
INE729D01010
Share Holding Pattern
Total Foreign (Promoter & Group)
0
Indian (Promoter & Group)
22296346
Total of Promoter
22296346
Non Promoter (Institution)
1092
Non Promoter (Non-Institution)
12664126
Total Non Promoter
12665218
Total Promoter & Non Promoter
34961564
Custodians(Against Depository Receipts)
0
Grand Total
34961564
News
Kilitch Drugs (India) Ltd
Kilitch Drugs (India) schedules EGM
14-Feb-2026
Read More
Kilitch Drugs (India) Ltd
Kilitch Drugs (India) schedules EGM
Kilitch Drugs (India) announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 13 March 2026.
Kilitch Drugs (India) Ltd
Kilitch Drugs (India) consolidated net profit..
12-Feb-2026
Read More
Kilitch Drugs (India) Ltd
Kilitch Drugs (India) consolidated net profit declines 25.67% in the December 2025 quarter
Net profit of Kilitch Drugs (India) declined 25.67% to Rs 4.43 crore in the quarter ended December 2025 as against Rs 5.96 crore during the previous quarter ended December 2024. Sales declined 4.20% to Rs 53.81 crore in the quarter ended December 2025 as against Rs 56.17 crore during the previous quarter ended December 2024.
Particulars
Quarter Ended
Dec. 2025
Dec. 2024
% Var.
Sales
53.81
56.17
-4
OPM %
11.43
15.54
-
PBDT
6.53
9.06
-28
PBT
5.60
8.25
-32
NP
4.43
5.96
-26
Kilitch Drugs (India) Ltd
Kilitch Drugs (India) announces board meeting..
05-Feb-2026
Read More
Kilitch Drugs (India) Ltd
Kilitch Drugs (India) announces board meeting date
Kilitch Drugs (India) will hold a meeting of the Board of Directors of the Company on 11 February 2026.
Kilitch Drugs (India) Ltd
Kilitch Drugs (India) consolidated net profit..
15-Nov-2025
Read More
Kilitch Drugs (India) Ltd
Kilitch Drugs (India) consolidated net profit declines 4.99% in the September 2025 quarter
Net profit of Kilitch Drugs (India) declined 4.99% to Rs 8.19 crore in the quarter ended September 2025 as against Rs 8.62 crore during the previous quarter ended September 2024. Sales rose 3.05% to Rs 48.92 crore in the quarter ended September 2025 as against Rs 47.47 crore during the previous quarter ended September 2024.
Particulars
Quarter Ended
Sep. 2025
Sep. 2024
% Var.
Sales
48.92
47.47
3
OPM %
10.30
12.85
-
PBDT
10.26
10.95
-6
PBT
9.40
10.35
-9
NP
8.19
8.62
-5
Kilitch Drugs (India) Ltd
Kilitch Drugs (India) to conduct board meetin..
11-Nov-2025
Read More
Kilitch Drugs (India) Ltd
Kilitch Drugs (India) to conduct board meeting
Kilitch Drugs (India) will hold a meeting of the Board of Directors of the Company on 13 November 2025.
Kilitch Drugs (India) Ltd
Kilitch Drugs (India) Ltd - Compliances-Certi..
14-Oct-2025
Read More
Kilitch Drugs (India) Ltd
Kilitch Drugs (India) Ltd - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
We are submitting herewith the certificate received from MUFG Intime India Private Limited for the quarter ended 30th September 2025 under Regulation 74(5) of SEBI (DP) Regulations
Kilitch Drugs (India) Ltd
Kilitch Drugs (India) Ltd - Shareholder Meeti..
27-Sep-2025
Read More
Kilitch Drugs (India) Ltd
Kilitch Drugs (India) Ltd - Shareholder Meeting / Postal Ballot-Scrutinizers Report
We are submitting the scrutinizer report
Kilitch Drugs (India) Ltd
Kilitch Drugs (India) Ltd - Shareholder Meeti..
26-Sep-2025
Read More
Kilitch Drugs (India) Ltd
Kilitch Drugs (India) Ltd - Shareholder Meeting / Postal Ballot-Outcome of AGM
We are enclosing herewith the proceeding and outcome of 33rd Annual General Meeting of the Company.
Kilitch Drugs (India) Ltd
Kilitch Drugs (India) Ltd - Closure of Tradin..
26-Sep-2025
Read More
Kilitch Drugs (India) Ltd
Kilitch Drugs (India) Ltd - Closure of Trading Window
The trading window will be closed for all designated person of the Company with effect from 1st October 2025 and will remain close till 48 hours from the declaration of financial results
Kilitch Drugs (India) Ltd
Kilitch Drugs (India) Ltd - Kilitch Drugs (In..
26-Sep-2025
Read More
Kilitch Drugs (India) Ltd
Kilitch Drugs (India) Ltd - Kilitch Drugs (India) Limited - Trading Window
Kilitch Drugs (India) Limited has informed the Exchange about Closure of Trading Window
Corporate Details
Board of Directors
Incorporation Year
1992
Chairman
Mukund P Mehta
Auditor
Suryaprakash Maurya & Co/C Sharat & Associates
Face Value
10
Market Lot
1
Listing
BSE,MSEI,NSE,
Registered Office
37 Ujagar Industrial Estate W T Patil Marg Deonar MR Maharashtra Mumbai400088
Contact
Telephone: 91-022-27670322/27680913/65144185
Fax: 91-022-27680912
Chairman & Managing Director
Mukund P Mehta
WTD & Executive Director
Bhavin M Mehta
Managing Director
Mira Mehta
Independent Non Exe. Director
VASUDEV KRISHNAMURTI
Venkita Subramanian Rajan
DIPEN JAYANTILAL JAIN
Company Sec. & Compli. Officer
Pushpa Nyoupane
Mutual Fund Holdings
1-0
of 0
Scheme Name
Amount Invested (Cr )
% Net Assets
Total Nav (Cr)
FAQ
What is the share price of Kilitch Drugs (India) Ltd today on NSE and BSE?
The Kilitch Drugs (India) Ltd Share price on NSE is Rs.154.02 and BSE Rs.153.30 as on today
How to buy Kilitch Drugs (India) Ltd shares Online?
You can easily open a Demat account online with Geojit and buy Kilitch Drugs (India) Ltd shares through Flip/Selfie – Geojit’s advanced trading platform.
What is the Market Capitalization of Kilitch Drugs (India) Ltd?
Market capitalization is a way of evaluating the value of a company. It refers to the total value of all a company's shares of stock. The market capitalization of Kilitch Drugs (India) Ltd is 535.96
What are the key financial ratios to analyse Kilitch Drugs (India) Ltd Share Price?
Kilitch Drugs (India) Ltd share can be evaluated based on following ratios as on March 2023
Shares P/E ratio: 17.99
ROE ratio: 11.02
Debt to Equity ratio: 0.17
EPS: 8.52
When did Kilitch Drugs (India) Ltd gave bonus shares last?
The issue of bonus shares enhances the company's value and improve positions in the market by gaining the trust of existing shareholders. The Kilitch Drugs (India) Ltd issued bonus shares last in 2026
What is the 52 week highest and lowest share price value of Kilitch Drugs (India) Ltd?
The highest share price value is Rs. 250.00 and Lowest share price value is Rs. 117.25 for 52 week period for Kilitch Drugs (India) Ltd.
Which ETF or Mutual Fund Holding has the highest amount invested with Kilitch Drugs (India) Ltd?
NA has the highest amount invested with Kilitch Drugs (India) Ltd.
Which year Kilitch Drugs (India) Ltd was incorporated?
Kilitch Drugs (India) Ltd was incorporated in 1992
What is the stock symbol of Kilitch Drugs (India) Ltd?
The stock symbol for Kilitch Drugs (India) Ltd shares is KILITCHDRUGS(INDIA)LTD.
Peer Comparison
Option Type
Balance Sheet
Financial Ratios
Profit & Loss
Select
Company Name
BSE Code
NSE Symbol
ABL Bio-Technologies Ltd
526955
Not Listed
Accretion Nutraveda Ltd
544694
Not Listed
ACE Laboratories Ltd
526077
ACELAB
Adline Chem Lab Ltd
524604
Not Listed
Aesculapius Remedies Ltd (Wound-up)
531786
Not Listed
Ahlcon Parenterals (India) Ltd
524448
Not Listed
Ajanta Pharma Ltd
532331
AJANTPHARM
Alps Laboratories Ltd
526003
Not Listed
American Remedies Ltd (Merged)
531534
Not Listed
Amrutanjan Health Care Ltd
590006
AMRUTANJAN
Please wait ...
Deliverable Volumes
Exchange
BSE
NSE
From Date
To Date
Date
Quantity Traded
Quantity Delivered
Change %
30 Apr 2026
24,616.00
10,499.00
42.65
29 Apr 2026
51,884.00
23,486.00
45.27
28 Apr 2026
37,909.00
15,418.00
40.67
27 Apr 2026
33,598.00
9,758.00
29.04
24 Apr 2026
68,016.00
37,538.00
55.19
23 Apr 2026
258,818.00
97,552.00
37.69
22 Apr 2026
254,546.00
107,497.00
42.23
21 Apr 2026
133,537.00
64,615.00
48.39
20 Apr 2026
55,512.00
26,498.00
47.73
17 Apr 2026
104,267.00
59,394.00
56.96
16 Apr 2026
61,382.00
40,297.00
65.65
15 Apr 2026
98,169.00
54,882.00
55.91
13 Apr 2026
55,958.00
26,068.00
46.58
10 Apr 2026
56,383.00
41,888.00
74.29
09 Apr 2026
57,042.00
38,719.00
67.88
08 Apr 2026
39,923.00
24,370.00
61.04
07 Apr 2026
156,863.00
123,170.00
78.52
06 Apr 2026
93,416.00
45,879.00
49.11
02 Apr 2026
10,083.00
5,566.00
55.20
01 Apr 2026
33,287.00
15,500.00
46.56
Please wait ...